CollPlant Biotechnologies (CLGN) Cash from Investing Activities (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Cash from Investing Activities of -$15000.0 for Q4 2025, down 1400.0% on a QoQ basis from -$1000.0 in Q3 2025, and up 74.14% year-over-year from -$8613.9 in Q4 2024.
CollPlant Biotechnologies (CLGN) Cash from Investing Activities (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$15000.0 for Q4 2025.
- Quarterly Cash from Investing Activities rose 74.14% year-over-year to -$15000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$77000.0 (up 85.71% YoY) and the FY2025 annual result came in at -$27000.0, up 94.99% from the prior year.
- Cash from Investing Activities was -$15000.0 for Q4 2025 at CollPlant Biotechnologies, down from -$1000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $29.9 million in Q1 2022 and bottomed at -$31.6 million in Q4 2021.
- A 5-year average of -$1.3 million and a median of -$243000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 7194.7% in 2021, while the deepest fall reached 35404.71% in 2021.
- CollPlant Biotechnologies' Cash from Investing Activities stood at -$31.6 million in 2021, then jumped by 99.04% to -$304000.0 in 2022, then slipped by 22.37% to -$372000.0 in 2023, then jumped by 84.41% to -$58000.0 in 2024, then soared by 74.14% to -$15000.0 in 2025.
- Business Quant data shows CLGN's Cash from Investing Activities at -$15000.0 in Q4 2025, -$1000.0 in Q3 2025, and -$3000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15,000.00 |
| Dec 31, 2025 | -15,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Dec 31, 2024 | -58,000.00 |
| Dec 31, 2024 | -58,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Sep 30, 2024 | -140,000.00 |
| Jun 30, 2024 | -259,000.00 |
| Jun 30, 2024 | -259,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Dec 31, 2023 | -372,000.00 |
| Dec 31, 2023 | -372,000.00 |
| Sep 30, 2023 | -243,000.00 |
| Sep 30, 2023 | -243,000.00 |
| Jun 30, 2023 | -396,000.00 |
| Jun 30, 2023 | -396,000.00 |